A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis. [PDF]
Sawa M +17 more
europepmc +1 more source
Synthesis of new pyrazolo[3,4-d]pyrimidines as potential mutant EGFR/HER2 and Bcl2 inhibitors: anticancer evaluation, DFT, molecular docking and ADME studies. [PDF]
Metwally NH, Saad ZA, Mohamed MS.
europepmc +1 more source
Parvovirus B19, Somatic Gene Mutations, and Hematologic Malignancy Subtypes: An Analytical Study. [PDF]
Khudhair AM +3 more
europepmc +1 more source
A novel mutation in exon 18 of <i>FGFR1</i> causing hypoparathyroidism: A case report. [PDF]
Cao X, Zhu Y, Sun R, Sun H.
europepmc +1 more source
Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia. [PDF]
Zhuang X +14 more
europepmc +1 more source
FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML. [PDF]
Stancioaica MC, Coriu D, Ghiaur G.
europepmc +1 more source
The Relationship between Training Load Indicators and the Total Quality Recovery Scale during the Preseason Period in Collegiate Taekwondo Athletes. [PDF]
Park CH, Jung HC.
europepmc +1 more source
Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study. [PDF]
Seçilmiş S +18 more
europepmc +1 more source

